Umstead John W. V
Chief Financial Officer at G1 Therapeutics, Inc.
- Sold, on record
- $62k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jul 5, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- G1 Therapeutics, Inc.Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale G1 Therapeutics, Inc.No planJan 4, 2024 2024
Sold 743 shares at $3.09 ($2k)
Umstead John W. V, Chief Financial Officer
No 10b5-1 planSold 0.6% of holdings ($406k position)130,443 shares leftFirst sale on recordFiling
- 2 Form 4 sale G1 Therapeutics, Inc.No planMar 18, 2024 +74 days
Sold 6,547 shares at $3.02 ($20k)
Umstead John W. V, Chief Financial Officer
No 10b5-1 planSold 5% of holdings ($394k position)123,896 shares leftFiling
- 3 Form 4 sale G1 Therapeutics, Inc.No planMay 13, 2024 +56 days
Sold 8,151 shares at $4.79 ($39k)
Umstead John W. V, Chief Financial Officer
No 10b5-1 planSold 5.1% of holdings ($773k position)153,245 shares leftFiling
- 4 Form 4 sale G1 Therapeutics, Inc.No planJul 5, 2024 +53 days
Sold 527 shares at $2.51 ($1k)
Umstead John W. V, Chief Financial Officer
No 10b5-1 planSold 0.3% of holdings ($472k position)187,718 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2024 | Jul 8, 2024 | G1 Therapeutics, Inc. | Chief Financial Officer | Form 4 sale | 527 | $1k | 0.3% | No plan | SEC |
| May 13, 2024 | May 15, 2024 | G1 Therapeutics, Inc. | Chief Financial Officer | Form 4 sale | 8,151 | $39k | 5.1% | No plan | SEC |
| Mar 18, 2024 | Mar 20, 2024 | G1 Therapeutics, Inc. | Chief Financial Officer | Form 4 sale | 6,547 | $20k | 5.0% | No plan | SEC |
| Jan 4, 2024 | Jan 8, 2024 | G1 Therapeutics, Inc. | Chief Financial Officer | Form 4 sale | 743 | $2k | 0.6% | No plan | SEC |